Kura Spins Out $50 Million Diabetes Biotech to Pursue a Potentially Disease-Changing Treatment

Kura Oncology is taking technology originally developed around cancer biology into the enormous diabetes market, launching a new company called Caspian Therapeutics with $50 million in financing to investigate whether menin inhibitors can restore the body’s ability to produce insulin. The scientific idea behind Caspian could represent an important departure from many existing diabetes treatments. […]